통합 의료 전달 네트워크 시장 : 통합 형태별, 환자 케어 모델별, 서비스 라인별, 소유 형태별, 용도별, 최종 사용자별 예측(2026-2032년)

The Integrated Delivery Network Market is projected to grow by USD 57.97 billion at a CAGR of 11.01% by 2032.

Integrated Delivery Networks (IDNs) are becoming central to healthcare modernization as hospitals, physician groups, ambulatory sites, post-acute providers, pharmacies, and digital care assets align under coordinated governance. The IDN model is supported by documented policy movement toward value-based care, interoperability, population health management, accountable care, and whole-person care coordination.

For executives, the strategic priority is no longer scale alone. Competitive advantage increasingly depends on enterprise-wide clinical integration, data liquidity, supply chain resilience, patient access, and measurable outcomes across the full continuum of care. As health systems respond to chronic disease prevalence, aging populations, workforce constraints, and rising expectations for digital engagement, IDNs are becoming a strategic operating model for improving quality, reducing avoidable utilization, and strengthening financial sustainability without relying solely on inpatient growth.

Transformative Shifts in the IDN Landscape

The IDN landscape is shifting from hospital-centric administration to distributed, digitally enabled care delivery. CMS alternative payment models, accountable care arrangements, price transparency rules, interoperability requirements, and payer-provider partnerships are pushing networks to coordinate care beyond acute settings. These changes are encouraging greater alignment among primary care, specialty care, behavioral health, pharmacy services, diagnostics, and post-acute providers.

At the same time, workforce shortages, rising chronic disease burden, and consumer expectations for convenient access are accelerating investment in ambulatory expansion, virtual care, home-based care, remote patient monitoring, and standardized clinical pathways. IDNs are also strengthening enterprise supply chain controls, centralized procurement, revenue cycle optimization, and digital front door capabilities as leaders seek more resilient operations and consistent patient experiences across care sites.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding IDN transformation by improving demand forecasting, clinical decision support, revenue cycle automation, documentation workflows, imaging triage, prior authorization support, capacity planning, and patient engagement. Its impact is strongest where IDNs have integrated data governance, clean master patient indexes, interoperable electronic health records, and consistent clinical terminology across settings.

Responsible adoption requires validation, bias monitoring, cybersecurity controls, privacy safeguards, explainability, and clinician oversight. IDNs that align AI with quality, safety, workforce productivity, and financial performance can convert fragmented data into operational intelligence. In practice, the most durable use cases are those embedded into existing workflows, monitored for real-world performance, and governed by multidisciplinary teams that include clinical, legal, compliance, information security, and analytics leaders.

Key Regional Insights

North America remains highly advanced in integrated delivery network adoption due to mature provider consolidation, broad electronic health record penetration, value-based reimbursement, accountable care participation, and payer-provider contracting. In the United States, federal policy around interoperability, price transparency, and alternative payment models continues to reinforce coordinated care, while Canada's provincial health systems emphasize access management, primary care reform, and digitally enabled coordination. Europe is advancing integrated care through public health system reforms, cross-border digital health policy, national eHealth strategies, and the European Health Data Space framework, with countries prioritizing aging care, chronic disease coordination, hospital-at-home models, and stronger links between primary and specialist care.

Asia-Pacific is scaling IDN-like models through universal health coverage programs, smart hospitals, national digital health infrastructure, and large investments in hospital modernization, with China, India, Japan, South Korea, Australia, and ASEAN economies pursuing different combinations of public insurance expansion, digital identity, telehealth, and regional care networks. Latin America is strengthening integrated care through private hospital groups, public-private collaboration, and urban specialty networks, particularly in Brazil and Mexico, while ongoing inequality and infrastructure gaps keep access expansion central to strategy. The Middle East is investing in health system modernization, insurance reform, medical tourism, and digital-first hospitals, especially across Gulf economies, while Africa is progressing through primary care networks, donor-supported digital health, community health programs, and regional efforts to expand access despite workforce, financing, and infrastructure constraints.

Key Group Insights

ASEAN markets are prioritizing hospital modernization, primary care access, universal health coverage progress, medical travel, and cross-border healthcare collaboration, creating demand for scalable integrated delivery models that can connect public hospitals, private providers, diagnostics, pharmacies, and digital health platforms. The GCC is advancing IDN development through national health transformation programs, insurance expansion, centralized purchasing, digital hospital investment, and care model redesign, with resilience, patient experience, and specialty care capacity positioned as major policy objectives.

The European Union is shaping integration through data-sharing rules, quality frameworks, cross-border healthcare coordination, cybersecurity policy, and public system reforms that encourage connected care pathways. BRICS countries are expanding access through large public programs, digital public infrastructure, and fast-growing private providers, making integrated care essential for managing scale, chronic disease, and urban-rural service gaps. G7 markets emphasize value-based care, aging population management, clinical standardization, and advanced digital health adoption, while NATO members increasingly link health system resilience to emergency preparedness, cyber defense, supply chain continuity, and the ability to sustain care delivery during public health or geopolitical disruptions.

Key Country Insights

The United States leads in IDN maturity, supported by large nonprofit and for-profit health systems, accountable care organization participation, value-based contracts, advanced revenue cycle infrastructure, and established interoperability policy. Canada emphasizes provincial integration, access management, primary care renewal, and digital health coordination, while Mexico and Brazil combine public health coverage with expanding private networks, urban specialty centers, and growing demand for coordinated chronic disease care. The United Kingdom is refining integrated care through system-level planning and closer collaboration between hospitals, primary care, social care, and community services, while Germany, France, Italy, and Spain are strengthening digital health, care coordination, and regional integration to address aging, workforce pressure, and budget discipline.

Russia continues to centralize parts of its healthcare infrastructure and expand digital health capabilities across a large geography, while China is scaling hospital networks, public insurance coverage, hierarchical diagnosis and treatment reforms, and national digital health platforms. India is expanding public insurance, digital health identity infrastructure, telemedicine, and private hospital networks to serve vast and diverse populations. Japan, Australia, and South Korea show strong alignment around aging care, health IT adoption, chronic disease management, and coordinated care pathways, with Japan focused on community-based integrated care, Australia emphasizing primary care and regional access, and South Korea advancing digital hospitals, insurance data infrastructure, and technology-enabled care management.

Actionable Recommendations for IDN Leaders

Industry leaders should prioritize interoperable data architecture, enterprise clinical governance, and measurable care pathway standardization. Investments should target patient access, ambulatory growth, chronic disease management, behavioral health integration, pharmacy coordination, and digitally supported home care where outcomes and cost benefits are most visible. IDNs should also strengthen digital front door capabilities, referral management, care navigation, and patient engagement tools to reduce leakage and improve continuity across sites of care.

Executives should strengthen AI governance, cybersecurity, workforce redesign, supplier diversification, and enterprise risk management. The most resilient IDNs will align capital allocation with value-based reimbursement, community health needs, regulatory compliance, and transparent performance metrics. Leaders should establish cross-functional operating models that connect clinical quality, finance, operations, data science, supply chain, and patient experience teams, ensuring that integration produces measurable improvements in access, safety, outcomes, and cost discipline.

Research Methodology

This executive summary is developed through secondary research using verified public sources, regulatory frameworks, health system policy documents, standards bodies, and industry-relevant publications. Sources considered include government health agencies, CMS policy direction, WHO and OECD health system references, interoperability standards, public digital health initiatives, regional health reform programs, and documented healthcare technology adoption trends.

The methodology emphasizes triangulation across policy, technology, reimbursement, provider operating trends, workforce dynamics, and regional health system reforms. Insights are synthesized to identify durable market drivers, regional differences, AI implications, and strategic priorities for integrated delivery network stakeholders. The analysis avoids market sizing, market share estimates, and forecasts, focusing instead on verified structural shifts, documented policy signals, and evidence-backed operational implications for IDNs.

Conclusion

Integrated Delivery Networks are evolving into digitally connected, outcome-driven ecosystems that coordinate care across settings. Their growth is reinforced by value-based reimbursement, interoperability mandates, consumer demand, aging populations, workforce constraints, and the need to manage complex chronic conditions at scale. Across regions, IDN strategies increasingly center on clinical integration, ambulatory expansion, digital health infrastructure, data governance, and resilient supply chains.

Organizations that combine clinical integration, responsible AI, resilient operations, and patient-centered access will be best positioned to improve quality, lower avoidable utilization, and compete in a rapidly changing healthcare environment. For healthcare leaders, the central mandate is clear: build integrated operating models that connect data, people, sites of care, and incentives around measurable outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Integrated Delivery Network Market, by Type of Integration

• 7.1. Horizontal Integration
  • 7.1.1. Hospital Chains
  • 7.1.2. Multi-hospital Systems
• 7.2. Vertical Integration

8. Integrated Delivery Network Market, by Patient Care Model

• 8.1. Fee-for-Service Models
• 8.2. Value-Based Care Models
• 8.3. Patient-Centered Medical Homes

9. Integrated Delivery Network Market, by Service Line

• 9.1. Acute Care Services
  • 9.1.1. Surgery
  • 9.1.2. Emergency Care
• 9.2. Ambulatory Care Services
• 9.3. Post-Acute Care Services
• 9.4. Behavioral Health Services
• 9.5. Specialty Care Services
  • 9.5.1. Oncology
  • 9.5.2. Cardiology
  • 9.5.3. Neurology

10. Integrated Delivery Network Market, by Ownership Model

• 10.1. Public IDNs
  • 10.1.1. Government-Owned Systems
  • 10.1.2. Municipal Health Systems
• 10.2. Private IDNs
  • 10.2.1. Non-Profit Organizations
  • 10.2.2. For-Profit Organizations
• 10.3. Hybrid Models

11. Integrated Delivery Network Market, by Application

• 11.1. Integrated EHR/EMR Systems
• 11.2. Patient Engagement Solutions
• 11.3. Population Health Management
• 11.4. Revenue Cycle Management
• 11.5. Revenue Intelligence

12. Integrated Delivery Network Market, by End User

• 12.1. Ambulatory Care Centers
• 12.2. Diagnostic Centers
• 12.3. Hospitals

13. Integrated Delivery Network Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Integrated Delivery Network Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Integrated Delivery Network Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Advocate Health
• 17.2. Banner Health
• 17.3. Baylor Scott & White Health
• 17.4. Centene Corporation
• 17.5. Community Health Systems Inc
• 17.6. CVS Health Corporation
• 17.7. Elevance Health Inc
• 17.8. Encompass Health Corporation
• 17.9. Fresenius Medical Care AG & Co KGaA
• 17.10. HCA Healthcare Inc
• 17.11. Humana Inc
• 17.12. Kaiser Foundation Health Plan Inc
• 17.13. LifePoint Health
• 17.14. Mayo Clinic Health System
• 17.15. Prime Healthcare Services
• 17.16. Providence Health & Services
• 17.17. Select Medical Corporation
• 17.18. Tenet Healthcare Corporation
• 17.19. Trinity Partners, LLC
• 17.20. UnitedHealth Group Inc
• 17.21. Universal Health Services Inc
• 17.22. UPMC